Clovis Oncology, Inc. Selling, General and Administrative Expense
Clovis Oncology, Inc. reported Selling, General and Administrative Expense of $30.38 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-11-09
- Clovis Oncology, Inc. selling, general and administrative expense for the quarter ending 2022-09-30 was $30.38M, a 5.64% decline year-over-year.
- Clovis Oncology, Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $32.59M, a 1.00% decline year-over-year.
- Clovis Oncology, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $29.21M, a 2.43% decline year-over-year.
- Clovis Oncology, Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $33.34M, a 18.19% decline year-over-year.
- Clovis Oncology, Inc. selling, general and administrative expense for fiscal 2021 was $128.40M, a 21.66% decline from fiscal 2020.
- Clovis Oncology, Inc. selling, general and administrative expense for fiscal 2020 was $163.89M, a 10.33% decline from fiscal 2019.
- Clovis Oncology, Inc. selling, general and administrative expense for fiscal 2019 was $182.77M, a 3.98% increase from fiscal 2018.
- Clovis Oncology, Inc. selling, general and administrative expense for fiscal 2018 was $175.78M, a 26.55% increase from fiscal 2017.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $30.38M 10-Q · filed 2022-11-09 | $62.97M derived: sum of 2 quarters · filed 2022-11-09 | $92.18M 10-Q · filed 2022-11-09 | $125.53M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $32.59M 10-Q · filed 2022-08-08 | $61.80M 10-Q · filed 2022-08-08 | $95.15M derived: sum of 3 quarters · filed 2022-08-08 | $127.34M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $29.21M 10-Q · filed 2022-05-05 | $62.56M derived: sum of 2 quarters · filed 2022-05-05 | $94.75M derived: sum of 3 quarters · filed 2022-11-09 | $127.67M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $33.34M 10-K · filed 2022-02-24 | $65.54M derived: sum of 2 quarters · filed 2022-11-09 | $98.46M derived: sum of 3 quarters · filed 2022-11-09 | $128.40M 10-K · filed 2022-02-24 |
| 2021-09-30 | $32.20M 10-Q · filed 2022-11-09 | $65.11M derived: sum of 2 quarters · filed 2022-11-09 | $95.06M 10-Q · filed 2022-11-09 | $135.81M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $32.92M 10-Q · filed 2022-08-08 | $62.86M 10-Q · filed 2022-08-08 | $103.62M derived: sum of 3 quarters · filed 2022-08-08 | $142.25M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $29.94M 10-Q · filed 2022-05-05 | $70.70M derived: sum of 2 quarters · filed 2022-05-05 | $109.33M derived: sum of 3 quarters · filed 2022-05-05 | $151.24M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $40.76M 10-K · filed 2022-02-24 | $79.39M derived: sum of 2 quarters · filed 2022-02-24 | $121.30M derived: sum of 3 quarters · filed 2022-02-24 | $163.89M 10-K · filed 2022-02-24 |
| 2020-09-30 | $38.64M 10-K · filed 2022-02-24 | $80.54M derived: sum of 2 quarters · filed 2022-02-24 | $123.14M 10-Q · filed 2021-11-03 | $168.30M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $41.90M 10-K · filed 2022-02-24 | $84.50M 10-Q · filed 2021-08-04 | $129.67M derived: sum of 3 quarters · filed 2022-02-24 | $171.48M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $42.60M 10-K · filed 2022-02-24 | $87.77M derived: sum of 2 quarters · filed 2022-02-24 | $129.58M derived: sum of 3 quarters · filed 2022-02-24 | $177.61M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $45.17M 10-K · filed 2021-02-25 | $86.98M derived: sum of 2 quarters · filed 2021-02-25 | $135.01M derived: sum of 3 quarters · filed 2021-02-25 | $182.77M 10-K · filed 2022-02-24 |
| 2019-09-30 | $41.81M 10-K · filed 2021-02-25 | $89.84M derived: sum of 2 quarters · filed 2021-02-25 | $137.60M 10-Q · filed 2020-11-05 | $186.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $48.03M 10-K · filed 2021-02-25 | $95.79M 10-Q · filed 2020-08-07 | $144.94M derived: sum of 3 quarters · filed 2021-02-25 | $187.43M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $47.76M 10-K · filed 2021-02-25 | $96.91M derived: sum of 2 quarters · filed 2021-02-25 | $139.40M derived: sum of 3 quarters · filed 2021-02-25 | $184.27M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $49.15M 10-K · filed 2020-02-26 | $91.64M derived: sum of 2 quarters · filed 2020-02-26 | $136.51M derived: sum of 3 quarters · filed 2020-02-26 | $175.78M 10-K · filed 2021-02-25 |
| 2018-09-30 | $42.49M 10-K · filed 2020-02-26 | $87.36M derived: sum of 2 quarters · filed 2020-02-26 | $126.63M 10-Q · filed 2019-11-07 | $165.16M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $44.86M 10-K · filed 2020-02-26 | $84.14M 10-Q · filed 2019-08-02 | $122.66M derived: sum of 3 quarters · filed 2020-02-26 | $157.67M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $39.27M 10-K · filed 2020-02-26 | $77.80M derived: sum of 2 quarters · filed 2020-02-26 | $112.81M derived: sum of 3 quarters · filed 2020-02-26 | $148.96M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $38.52M 10-K · filed 2019-02-28 | $73.53M derived: sum of 2 quarters · filed 2019-02-28 | $109.68M derived: sum of 3 quarters · filed 2019-02-28 | $138.91M 10-K · filed 2020-02-26 |
| 2017-09-30 | $35.01M 10-K · filed 2019-02-28 | $71.16M derived: sum of 2 quarters · filed 2019-02-28 | $100.38M 10-Q · filed 2018-11-01 | $112.57M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $36.15M 10-K · filed 2019-02-28 | $65.37M 10-Q · filed 2018-08-02 | $77.56M derived: sum of 3 quarters · filed 2019-02-28 | $86.72M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $29.22M 10-K · filed 2019-02-28 | $41.41M derived: sum of 2 quarters · filed 2019-02-28 | $50.58M derived: sum of 3 quarters · filed 2019-02-28 | $60.13M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $12.19M 10-K · filed 2018-02-27 | $21.35M derived: sum of 2 quarters · filed 2018-02-27 | $30.90M derived: sum of 3 quarters · filed 2018-02-27 | $40.73M 10-K · filed 2019-02-28 |
| 2016-09-30 | $9.16M 10-K · filed 2018-02-27 | $18.71M derived: sum of 2 quarters · filed 2018-02-27 | $28.54M 10-Q · filed 2017-11-02 | $36.78M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $9.55M 10-K · filed 2018-02-27 | $19.38M 10-Q · filed 2017-08-03 | $27.62M derived: sum of 3 quarters · filed 2018-02-27 | $35.95M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $9.83M 10-K · filed 2018-02-27 | $18.07M derived: sum of 2 quarters · filed 2018-02-27 | $26.40M derived: sum of 3 quarters · filed 2018-02-27 | $33.60M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $8.24M 10-K · filed 2017-02-23 | $16.57M derived: sum of 2 quarters · filed 2017-02-23 | $23.77M derived: sum of 3 quarters · filed 2017-02-23 | $30.52M 10-K · filed 2018-02-27 |
| 2015-09-30 | $8.33M 10-K · filed 2017-02-23 | $15.54M derived: sum of 2 quarters · filed 2017-02-23 | $22.29M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-06-30 | $7.20M 10-K · filed 2017-02-23 | $13.96M derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $6.75M 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $21.46M 10-K · filed 2017-02-23 |